GLP-1 (Glucagon-like peptide-1) agonists are innovative medications designed to support weight loss and improve metabolic health. At Fleming Adult Health NP, we follow evidence-based guidelines to ensure these treatments are safe, effective, and tailored to your individual needs.
Hereβs how we approach GLP-1 agonist therapy:
π« BMI Criteria: GLP-1 agonists may be recommended for individuals with a BMI of 30 or higher or a BMI of 27 or higher when weight-related conditions such as high blood pressure, high cholesterol, or type 2 diabetes are present.
π« Weight-Related Comorbidities: These medications are especially beneficial for those managing obesity alongside related health challenges, particularly when other weight-loss methods have not been effective.
π« Individualized Treatment Plans: We carefully assess your health history, current conditions, and past weight-loss experiences to create a personalized treatment plan that fits your goals and lifestyle.
Our goal is to empower you with tools and guidance to achieve and maintain your health and wellness objectives.
At Fleming Adult Health NP, we are committed to providing safe and effective care by adhering to evidence-based guidelines for prescribing GLP-1 medications. We follow established BMI criteria to determine eligibility, ensuring these treatments are used appropriately for patients with clinical indications such as obesity or overweight with associated health conditions. Additionally, we recognize the importance of ongoing medication support for patients who have successfully reached their BMI goals. Our team offers maintenance therapy tailored to help sustain weight loss, optimize overall health, and prevent weight regain, all while prioritizing a patient-centered approach that supports long-term wellness.
Copyright Β© 2023-Fleming Adult Health NP, PLLC- All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.